Clinical Trials Browser

Phase 2 × urelumab × Gastrointestinal × Clear all

NCT02451982 2026-06-01

Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms